Investigating isoquinoline derivatives for inhibition of inhibitor of apoptosis proteins for ovarian cancer treatment

References

• HanahanDWeinbergRAHallmarks of cancer: the next generationCell20111445 646 67421376230
   PubMed Web of Science ®Google Scholar
• FuldaSVucicDTargeting IAP proteins for therapeutic intervention in cancerNat Rev Drug Discov2012112 109 12422293567
   PubMed Web of Science ®Google Scholar
• GillCDowlingCO’NeillAJWatsonRWEffects of cIAP-1, cIAP-2 and XIAP triple knockdown on prostate cancer cell susceptibility to apoptosis, cell survival and proliferationMol Cancer20098 3919549337
   PubMed Web of Science ®Google Scholar
• LaCasseECMahoneyDJCheungHHPlenchetteSBairdSKornelukRGIAP-targeted therapies for cancerOncogene20082748 6252 627518931692
   PubMed Web of Science ®Google Scholar
• SongZYaoXWuMDirect interaction between survivin and Smac/DIABLO is essential for the anti-apoptotic activity of survivin during taxol-induced apoptosisJ Biol Chem200327825 23130 2314012660240
   PubMed Web of Science ®Google Scholar
• FuldaSRegulation of cell migration, invasion and metastasis by IAP proteins and their antagonistsOncogene2014336 671 67623474760
   PubMed Web of Science ®Google Scholar
• FuldaSInhibitor of apoptosis (IAP) proteins as therapeutic targets for radiosensitization of human cancersCancer Treat Rev2012386 760 76622342104
   PubMed Web of Science ®Google Scholar
• WenXLinZQLiuBWeiYQCaspase-mediated programmed cell death pathways as potential therapeutic targets in cancerCell Prolif2012453 217 22422429822
   PubMed Web of Science ®Google Scholar
• VucicDFairbrotherWJThe inhibitor of apoptosis proteins as therapeutic targets in cancerClin Cancer Res20071320 5995 600017947460
   PubMed Web of Science ®Google Scholar
• YangXXingHGaoQRegulation of HtrA2/Omi by X-linked inhibitor of apoptosis protein in chemoresistance in human ovarian cancer cellsGynecol Oncol2005972 413 42115863139
   PubMed Web of Science ®Google Scholar
• MehrotraSLanguinoLRRaskettCMMercurioAMDohiTAltieriDCIAP regulation of metastasisCancer Cell2010171 53 6420129247
   PubMed Web of Science ®Google Scholar
• González-LópezMWelshKFinlayDDesign, synthesis and evaluation of monovalent Smac mimetics that bind to the BIR2 domain of the anti-apoptotic protein XIAPBioorg Med Chem Lett20112114 4332 433621680182
   PubMed Web of Science ®Google Scholar
• BoulahjarROuachAMatteoCNovel tetrahydropyrido[1,2-a] isoindolone derivatives (valmerins): potent cyclin-dependent kinase/glycogen synthase kinase 3 inhibitors with antiproliferative activities and antitumor effects in human tumor xenograftsJ Med Chem20125522 9589 960623083119
   PubMed Web of Science ®Google Scholar
• MorrisGFMathewsMBRegulation of proliferating cell nuclear antigen during the cell cycleJ Biol Chem198926423 13856 138642569465
   PubMed Web of Science ®Google Scholar
• ZhengDChenZLiuJWuJAn efficient route to 1-aminoisoquinolines via AgOTf-catalyzed reaction of 2-alkynylbenzaldoxime with amineOrg Biomol Chem2011913 4763 476521617812
   PubMed Web of Science ®Google Scholar
• ZhengDLiSWuJAn unexpected silver triflate catalyzed reaction of 2-alkynylbenzaldehyde with 2-isocyanoacetateOrg Lett20121411 2655 265722616758
   PubMed Web of Science ®Google Scholar
• FaniSKamalidehghanBLoKMHashimNMChowKMAhmadipourFSynthesis, structural characterization, and anticancer activity of a monobenzyltin compound against MCF-7 breast cancer cellsDrug Des Devel Ther20159 6191 6201
   PubMed Web of Science ®Google Scholar
• YaoZSunBHongQPACE4 regulates apoptosis in human prostate cancer cells via endoplasmic reticulum stress and mitochondrial signaling pathwaysDrug Des Devel Ther20159 5911 5923
   Web of Science ®Google Scholar
• JinRXiaYChenQDa0324, an inhibitor of nuclear factor-kappaB activation, demonstrates selective antitumor activity on human gastric cancer cellsDrug Des Devel Ther201610 979 995
   PubMed Web of Science ®Google Scholar
• JinZNiuHWangXZhangLWangQYangAPreclinical study of CC223 as a potential anti-ovarian cancer agentOncotarget Epub2017510
   Google Scholar
• JiangSChenXHMGB1 siRNA can reduce damage to retinal cells induced by high glucose in vitro and in vivoDrug Des Devel Ther201711 783 795
   PubMed Web of Science ®Google Scholar
• PalaŞAtilganRKuloğluTProtective effects of vitamin C and vitamin E against hysterosalpingography-induced epithelial degeneration and proliferation in rat endometriumDrug Des Devel Ther201610 4079 4089
   PubMed Web of Science ®Google Scholar
• PandeySAldose reductase inhibitor fidarestat as a promising drug targeting autophagy in colorectal carcinoma: a pilot studyAsian Pac J Cancer Prev20151612 4981 498526163626
   PubMedGoogle Scholar
• KadivarAKamalidehghanBAkbari JavarHKarimiBSedghiRNoordinMIAntiproliferation effect of imatinib mesylate on MCF7, T-47D tumorigenic and MCF 10A nontumorigenic breast cell lines via PDGFR-beta, PDGF-BB, c-Kit and SCF genesDrug Des Devel Ther201711 469 481
   Web of Science ®Google Scholar
• RenFShenJShiHHornicekFJKanQDuanZNovel mechanisms and approaches to overcome multidrug resistance in the treatment of ovarian cancerBiochim Biophys Acta201618662 266 27527717733
   PubMed Web of Science ®Google Scholar
• HuangRLeungIKProtein-directed dynamic combinatorial chemistry: a guide to protein ligand and inhibitor discoveryMolecules2016217 pii:E910
   Web of Science ®Google Scholar
• NarayanaKKCAswathanarayanJBVittalRREndophytic peptides – a source of therapeutic agentsCurr Protein Pept Sci2017183 284 29027784222
   PubMed Web of Science ®Google Scholar
• SchreiberSLTarget-oriented and diversity-oriented organic synthesis in drug discoveryScience20002875460 1964 196910720315
   PubMed Web of Science ®Google Scholar
• VarfolomeevEGoncharovTMaeckerHCellular inhibitors of apoptosis are global regulators of NF-kappaB and MAPK activation by members of the TNF family of receptorsSci Signal20125216 ra2222434933
   PubMed Web of Science ®Google Scholar
• Birkey ReffeySWurthnerJUParksWTRobertsABDuckettCSX-linked inhibitor of apoptosis protein functions as a cofactor in transforming growth factor-beta signalingJ Biol Chem200127628 26542 2654911356828
   PubMed Web of Science ®Google Scholar
• Hofer-WarbinekRSchmidJAStehlikCBinderBRLippJde MartinRActivation of NF-kappa B by XIAP, the X chromosome-linked inhibitor of apoptosis, in endothelial cells involves TAK1J Biol Chem200027529 22064 2206810807933
   PubMed Web of Science ®Google Scholar
• BeugSTCheungHHLaCasseECKornelukRGModulation of immune signalling by inhibitors of apoptosisTrends Immunol20123311 535 54522836014
   PubMed Web of Science ®Google Scholar
• LopezJMeierPTo fight or die – inhibitor of apoptosis proteins at the crossroad of innate immunity and deathCurr Opin Cell Biol2010226 872 88120888210
   PubMed Web of Science ®Google Scholar
• FuldaSPromises and challenges of Smac mimetics as cancer therapeuticsClin Cancer Res20152122 5030 503626567362
   PubMed Web of Science ®Google Scholar
• LaCasseECPulling the plug on a cancer cell by eliminating XIAP with AEG35156Cancer Lett20133322 215 22422776562
   PubMed Web of Science ®Google Scholar
• StraubCSTargeting IAPs as an approach to anti-cancer therapyCurr Top Med Chem2011113 291 31621320059
   PubMed Web of Science ®Google Scholar
• FuldaSMolecular pathways: targeting death receptors and smac mimeticsClin Cancer Res20142015 3915 392024824309
   PubMed Web of Science ®Google Scholar
• TalbottRLBorzilleriRMChaudhryCPharmacology of smac mimetics; chemotype differentiation based on physical association with caspase regulators and cellular transportExp Cell Res20153382 251 26026302264
   PubMed Web of Science ®Google Scholar
• WangSDesign of small-molecule Smac mimetics as IAP antagonistsCurr Top Microbiol Immunol2011348 89 11321072626
   PubMed Web of Science ®Google Scholar
• LiLThomasRMSuzukiHDe BrabanderJKWangXHarranPGA small molecule Smac mimic potentiates TRAIL- and TNFalpha-mediated cell deathScience20043055689 1471 147415353805
   PubMed Web of Science ®Google Scholar
• SunHNikolovska-ColeskaZLuJDesign, synthesis, and characterization of a potent, nonpeptide, cell-permeable, bivalent Smac mimetic that concurrently targets both the BIR2 and BIR3 domains in XIAPJ Am Chem Soc200712949 15279 1529417999504
   PubMed Web of Science ®Google Scholar
• KimKSZhangLWilliamsDDiscovery of tetrahydroisoquinoline-based bivalent heterodimeric IAP antagonistsBioorg Med Chem Lett20142421 5022 502925278234
   PubMed Web of Science ®Google Scholar
• PandeyMKPrasadSTyagiAKTargeting cell survival proteins for cancer cell deathPharmaceuticals (Basel)201691 pii:E11
   Google Scholar